Novavax, Inc.
Coronavirus vaccine formulations
Last updated:
Abstract:
Disclosed herein are coronavirus Spike (S) proteins and nanoparticles comprising the same, which are suitable for use in vaccines. The nanoparticles present antigens from pathogens surrounded to and associated with a detergent core resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.
Status:
Grant
Type:
Utility
Filling date:
19 Aug 2020
Issue date:
23 Mar 2021